Torrent in Rs 18,000 crore deal, 2nd largest in pharma sector

Torrent Pharmaceuticals has announced an ₹18,000 crore deal, marking it as the second largest in the pharma sector. This massive acquisition or investment signifies a major consolidation move within the Indian pharmaceutical industry. Such a large-scale transaction will significantly impact Torrent Pharma's market position, product portfolio, and overall business strategy, potentially leading to increased market share, broader therapeutic presence, or enhanced R&D capabilities. This deal highlights the dynamic nature of the pharma sector, driven by strategic mergers and acquisitions to achieve growth and market leadership.